EVGN stock news · Evogene Ltd.

Stories about Evogene Ltd. (EVGN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for EVGN

Follow Evogene Ltd. (EVGN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Oct 30, 2026, 3:25 AM ET · Market
Evogene is now focusing on finding new drugs for acute graft-versus-host disease using its AI program.
Good for EVGN
Evogene named acute graft-versus-host disease as a focus for its AI drug research and has generated candidate molecules. This is a positive step, but no patient results are reported.
Oct 22, 2026, 2:05 AM ET · Market
Evogene will join a tour on the U.S. East Coast to showcase AI in drug discovery.
Neutral
Evogene is set to join an AI drug discovery roadshow. The story reports no new business result, so the appearance alone does not change its outlook.
Oct 7, 2026, 5:12 PM ET · Market
12 health care companies saw big changes in their stock prices after the market closed on Wednesday.
Neutral
Evogene shares fell 6.97% to $0.38 after hours, but the roundup gives no company news, so its business outlook is unchanged.
Oct 2, 2026, 5:12 PM ET · Market
On Friday evening, 12 health care stocks saw big changes in their prices.
Neutral
Evogene's shares fell about 5% after hours, but the report gives no company news to change its business outlook.
Sep 29, 2026, 5:22 PM ET · Market
12 health care stocks changed a lot in prices after the market closed on Tuesday.
Neutral
Evogene shares rose 75% after hours, but the article reports no company news behind the move. It does not change the company's business outlook.